
Shamir Geller/mskcc.org
Apr 20, 2025, 16:21
Shamir Geller: Our experience with JAK inhibitors in patients with cutaneous lymphoma
Shamir Geller, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn about a paper he co-authored published in the Journal of Dermatology:
“Just accepted for publication – our experience with JAK inhibitors in patients with cutaneous lymphoma from our Memorial Sloan Kettering Cancer Center cutaneous lymphoma clinic.
More on this topic to come…”
Authors: Viviane Liao, Leore Lavin, Michael Ong, Melissa Pulitzer, Alison Moskowitz, Patricia Myskowski, Shamir Geller.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 14:14
May 10, 2025, 14:11
May 10, 2025, 13:57